Atherosclerotic peripheral vascular disease symposium II intervention for renal artery disease

Circulation

Volumn 118, Issue 25, 2008, Pages 2873-2878

  Rocha Singh, Krishna J ^a   Eisenhauer, Andrew C ^a   Textor, Stephen C ^a   Cooper, Christopher J ^a   Tan, Walter A ^a   Matsumoto, Alan H ^a   Rosenfield, Kenneth ^a  

^a NONE

Author keywords

AHA conference proceedings; Atheroembolism; Ischemic nephropathy; Peripheral arterial disease; Renal artery intervention

Indexed keywords

ARTERY DISEASE; ATHEROSCLEROSIS; CATHETERIZATION; CONFERENCE PAPER; EMBOLISM; KIDNEY DISEASE; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; TREATMENT INDICATION;

AMERICAN HEART ASSOCIATION; ANIMALS; ATHEROSCLEROSIS; HUMANS; PERIPHERAL VASCULAR DISEASES; RENAL ARTERY OBSTRUCTION; UNITED STATES;

EID: 58249141336     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.191178     Document Type: Conference Paper

References (50)

1. Garovic V, Textor SC. Renovascular hypertension: current concepts. Semin Nephrol. 2005;25:261-271.
2. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362-1374.
3. Conlon P, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490-1497.
4. White CJ, Jaff MR, Haskal ZJ, Jones DJ, Olin JW, Rocha-Singh KJ, Rosenfield KA, Rundback JH, Linas SL. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation. 2006;114:1892-1895.
5. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervention, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). Circulation. 2006;113:e463-e654.
6. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W, Dworkin L. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59-66.
7. Zeller T, Frank U, Müller C, Bürgelin K, Sinn L, Bestehorn HP, Cook-Bruns N, Neumann FJ. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
8. Muray S, Martín M, Amoedo ML, García C, Jornet AR, Vera M, Oliveras A, Gómez X, Craver L, Real MI, García L, Botey A, Montanyà X, Fernández E. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39:60-66.
9. Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol. 2001;12:1235-1241.
10. Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Cathet Cardiovasc Interv. 2002;57:135-141.
11. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293-301.
12. Dorros G, Jaff M, Mathiak L, He T; Multicenter Registry Participants. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
13. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15:1974-1982.
14. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, Waldek S, Kalra PA. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol. 2002;13:149-157.
15. Paulsen D, Kløw NE, Rogstad B, Leivestad T, Lien B, Vatne K, Fauchald P. Preservation of renal function by percutaneous transluminal angioplasty in ischemic renal disease. Nephrol Dial Transplant. 1999;14:1454-1461.
16. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, Chew P, Gilbert SJ, Lau J. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145:901-912.
17. Lim ST, Rosenfield K. Renal artery stent placement: indications and results. Curr Interv Cardiol Rep. 2000;2:130-139.
18. Thadhani RI, Camargo CA Jr, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine (Baltimore). 1995;74:350-358.
19. Liew YP, Bartholomew JR. Atheromatous embolization. Vasc Med. 2005;10:309-326.
20. Scolari F, Ravani P, Pola A, Guerini S, Zubani R, Movilli E, Savoldi S, Malberti F, Majorca R. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. 2003;14:1584-1590.
21. Kolluri R, Goldstein JA, Rocha-Singh K. Percutaneous vascular interventions in renal artery diseases. Minerva Cardioangiol. 2006;54:95-107.
22. Hiromoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex-vivo study. J Vasc Surg. 2005;41:1026-1030.
23. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G, Rajacopal S, Hugel M. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv. 2003;60:299-312.
24. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J, Geary RL, Hansen KJ. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. 2006;44:128-135.
25. Holden A, Hill A, Jaff MR, Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int. 2006;70:948-955.
26. Edwards MS, Corriere MA, Craven TE, Pan XM, Rapp JH, Pearce JD, Mertaugh NB, Hansen KJ. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg. 2007;46:55-61.
27. Carter A, Tsao P. Histopathology of restenosis. In: Serruys PW, Gershlick AH, eds. Handbook of Drug-Eluting Stents. London. United Kingdom: Informa HealthCare; 2005:15-24.
28. Nikolsky E, Mehran R, Ashby D, Dangas G, Lansky A, Stone G, Moses J, Leon M. Restenosis following percutaneous coronary interventions: a clinical problem. In: Serruys PW, Gershlick AH, eds. Handbook of Drug-Eluting Stents. London, United Kingdom: Informa HealthCare: 2005:3-14.
29. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, Man In 't Veld. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
30. Rocha-Singh K, Jaff M, Rosenfield K; ASPIRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776-783.
31. Vignali C, Bargellini I, Lazzereschi M, Cioni R, Petruzzi P, Caramella D. Pinto S, Napoli V, Zampa V, Bartolozzi C. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol. 2005;28:296-302.
32. Shammas NW, Kapalis MJ, Dippel EJ, Jerin MJ, Lemke JH, Patel P, Harris M. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol. 2004;16:10-13.
33. Nolan BW, Schermerhom ML, Powell RJ, Rowell E, Fillinger MF, Rzucidlo EM, Wyers MC, Whittaker D, Zwolak RM, Walsh DB, Cronenwett JL. Restenosis in gold-coated renal artery stenosis. J Vasc Surg. 2005;42:40-46.
34. Leertouwer TC, Gussenhoven EJ, van Overhagen H, Man in 't Veld AJ, van Jaarsveld BC. Stent placement for treatment of renal artery stenosis guided by intravascular ultrasound. J Vasc Interv Radiol. 1998;9:945-952.
35. Bax L, Mali WP, Van De Ven PJ, Beek FJ, Vos JA, Beutler JJ. Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol. 2002;13:1219-1224.
36. Wöhrle J, Kochs M, Vollmer C, Kestler HA, Hombach V, Höher M, Re-angioplasty of in-stent restenosis versus balloon restenosis: a matched pair comparison. Int J Cardiol. 2004;93:257-262.
37. Rabin Y, Taylor MJ, Wolmark N. Thermal expansion measurements of frozen biological tissues at cryogenic temperatures. J Biomech Eng. 1998;120:259-266.
38. Mandeville AF, McCabe BF. Some observations on the cryobiology of blood vessels. Laryngoscope. 1967;77:1328-1350.
39. Baust JM. Molecular mechanisms of cellular demise associated with cryopreservation failure. Cell Preserv Technol. 2002;1:17-32.
40. Tatsutani KN, Joye JD, Virmani R, Taylor MJ. In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing. Cryo Letters. 2005;26:55-64.
41. Stoeteknuel-Friedli S, Do DD, Von Briel C, Triller J, Mahler F, Baumgartner I. Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther. 2002;9:350-353.
42. Jahraus CD, St Clair W, Gurley J, Meigooni AS. Endovascular brachytherapy for the treatment of renal artery in-stent restenosis using a betaemitting source: a report of five patients. South Med J. 2003;96:1165-1168.
43. Chrysant GS. Goldstein JA, Casserly IP, Rogers JH, Kurz HI, Thorstad WL, Singh J, Lasala JM. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Catheter Cardiovasc Interv. 2003;59:251-254.
44. Sapoval M, Zähringer M, Pattynama P, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanow ska M, Jaschke W, Hafsahl G, Dowries M, Beregi JP, Veeger N, Talen A. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial. J Vasc Interv Radiol. 2005;16:1195-1202.
45. Munneke GJ, Engelke C, Morgan RA, Belli AM. Cutting balloon angioplasty for resistant renal artery in-stent restenosis. J Vasc Intev Radiol. 2002;13:327-331.
46. Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo AM, Schutz D, Raizner AE, Palacios I, O'Neill W, Kaluza GL, Stone G; ORAR II Investigators. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective. Randomized Oral Rapamycin in Argentina (ORAR II) Study. J Am Coll Cardiol. 2006;47:1522-1529.
47. Koo BK, Kim YS, Park KW, Yang HM, Kwon DA, Chung JW, Hahn JY, Lee HY, Park JS, Kang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study [published correction appears in Lancet. 2007;370:828]. Lancet. 2007;370:567-574.
48. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-2124.
49. Rees CR. Stents for atherosclerotic renovascular disease (published correction appears in J Vasc Interv Radiol. 1999;10:1118).
50. J Vasc Interv Radiol. 1999;10:689-705.